insitro
Not publicly tradedinsitro, founded by Daphne Koller, combines machine learning with human cellular data to identify disease drivers and design drug candidates. It has…
insitro, founded by Daphne Koller, combines machine learning with human cellular data to identify disease drivers and design drug candidates. It has…
DeepTech + MedTechFrom over-the-counter glucose monitors to AI-enabled imaging software, medical devices are getting smaller, smarter and more autonomous. Here is what is authorized, what is still experimental, and what could slow things down.
LongevitySome longevity metrics, like blood pressure, are backed by decades of evidence and clear actions. Others, like consumer biological-age tests, are promising research tools whose meaning for individuals is not yet settled.
AI + MedicinePersonalized computer models of the heart and in-silico trials are already used in research and regulation. Scaling them into a living digital twin for every patient raises hard questions of biology, validation and trust.